Cargando…

Absorption, metabolism and excretion of [(14)C]pomalidomide in humans following oral administration

PURPOSE: To investigate the pharmacokinetics and disposition of [(14)C]pomalidomide following a single oral dose to healthy male subjects. METHODS: Eight subjects were administered a single 2 mg oral suspension of [(14)C]pomalidomide. Blood (plasma), urine and feces were collected. Mass balance of r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann, Matthew, Kasserra, Claudia, Reyes, Josephine, Schafer, Peter, Kosek, Jolanta, Capone, Lori, Parton, Anastasia, Kim-Kang, Heasook, Surapaneni, Sekhar, Kumar, Gondi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556473/ https://www.ncbi.nlm.nih.gov/pubmed/23203815 http://dx.doi.org/10.1007/s00280-012-2040-6

Ejemplares similares

Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects
por: Chen, Nianhang, et al.
Publicado: (2011)

Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration
por: Hoffmann, Matthew, et al.
Publicado: (2011)

Absorption, Distribution, and Excretion of (14)C-APX001 after Single-Dose Administration to Rats and Monkeys
por: Mansbach, Robert, et al.
Publicado: (2017)

Absorption, distribution, metabolism, and excretion of [(14)C]‐dasotraline in humans
por: Chen, Yu‐Luan, et al.
Publicado: (2016)

Absorption, Metabolism, and Excretion of [(14)C]-Tolebrutinib After Oral Administration in Humans, Contribution of the Metabolites to Pharmacological Activity
por: Nicolas, Olivier, et al.
Publicado: (2023)

Absorption and Excretion of Antipyrine
Publicado: (1888)

Distribution of pomalidomide into semen of healthy male subjects after multiple doses
por: Li, Yan, et al.
Publicado: (2018)

Absorption, distribution, metabolism, and excretion of [(14)C]-labeled naloxegol in healthy subjects
por: Bui, Khanh, et al.
Publicado: (2015)

Absorption, metabolism, excretion, and safety of [(14)C]almonertinib in healthy Chinese subjects
por: Zhou, Chen, et al.
Publicado: (2021)

In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects
por: Li, Yan, et al.
Publicado: (2018)

No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
por: Chen, Nianhang., et al.
Publicado: (2014)

Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
por: Chen, Nianhang, et al.
Publicado: (2014)

Absorption, Distribution and Excretion of (14)C-Probimane in Mice Bearing Lewis Lung Carcinoma
por: Lu, Da-Yong, et al.
Publicado: (2010)

Population Pharmacokinetics of Pomalidomide
por: Li, Yan, et al.
Publicado: (2015)

Pomalidomide-induced hypothyroidism
por: Ali, Sulaiman Haji, et al.
Publicado: (2017)

Absorption, metabolism, and excretion of [(14)C]ponatinib after a single oral dose in humans
por: Ye, Yihua E., et al.
Publicado: (2017)

In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine
por: Chen, Yong, et al.
Publicado: (2010)

An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics
por: Li, Yan, et al.
Publicado: (2018)

Pomalidomide for the Treatment of Multiple Myeloma
por: Clark, Stephen M., et al.
Publicado: (2014)

Absorption, Distribution, Excretion, and Pharmacokinetics of (14)C-Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats
por: Park, Sang Hyun, et al.
Publicado: (2010)

Diet in Disease: X.—Digestion—Absorption—Excretion
por: Hart, Ernest
Publicado: (1892)

A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension
por: Li, Yan, et al.
Publicado: (2018)

Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration
por: Cho, Wan-Seob, et al.
Publicado: (2013)

Absorption, Distribution, Metabolism, and Excretion of [(14)C]-Volixibat in Healthy Men: Phase 1 Open-Label Study
por: Siebers, Nicholas, et al.
Publicado: (2017)

Absorption, Metabolism, and Excretion of [(14)C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects
por: Gupta, Vipul K., et al.
Publicado: (2023)

Spotlight on pomalidomide: could less be more?
por: Zander, T, et al.
Publicado: (2017)

Observations on the Absorption, Excretion, Diffusion, and Acetylation of Sulfadiazine in Man
por: Sadusk, Joseph F., et al.
Publicado: (1941)

Observations on the Absorption, Excretion, Diffusion, and Acetylation of Sulfathiazole in Man
por: Sadusk, Joseph F., et al.
Publicado: (1940)

Absorption, distribution, metabolism and excretion of molidustat in healthy participants
por: Lentini, Silvia, et al.
Publicado: (2020)

Absorption, metabolism and excretion of opicapone in human healthy volunteers
por: Loureiro, Ana I., et al.
Publicado: (2022)

Profile of pomalidomide and its potential in the treatment of myelofibrosis
por: Gowin, Krisstina L, et al.
Publicado: (2015)

Pomalidomide Reduces Ischemic Brain Injury in Rodents
por: Tsai, Yan-Rou, et al.
Publicado: (2019)

Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma
por: Modi, Dipenkumar, et al.
Publicado: (2015)

Lycopene: A Critical Review of Digestion, Absorption, Metabolism, and Excretion
por: Arballo, Joseph, et al.
Publicado: (2021)

Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans
por: Nussbaum, Jesse C., et al.
Publicado: (2022)

Investigation of Intestinal Absorption and Excretion of Paracetamol in Streptozotocin-Induced Hyperglycemia
por: Mészáros, Petra, et al.
Publicado: (2022)

Absorption, metabolism, and excretion of [ (14)C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers
por: Tsuda, Minoru, et al.
Publicado: (2023)

New drugs in multiple myeloma – role of carfilzomib and pomalidomide
por: Jurczyszyn, Artur, et al.
Publicado: (2014)

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
por: Chanan-Khan, A A, et al.
Publicado: (2013)

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
por: Sivaraj, Dharshan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gkv1of489i5pl18n5mqopm63k3